CHA Global Clinical Trials Center director Dr Young-Sang Kim (left), and HiRO founder and CEO Dr Karen Chu (right) sign the MOU. Credit: Harvest Integrated Research Organization (HiRO)/PRNewswire.

Harvest Integrated Research Organization (HiRO) has announced a strategic partnership through the signing of a memorandum of understanding (MOU) with CHA University Bundang Medical Center (CBMC) to deliver comprehensive solutions to pharmaceutical and biotech companies globally, covering all phases of clinical trials (Phase I to Phase IV).

The collaboration also aims to streamline trial processes, drive advancements, and foster innovation in healthcare research both regionally and globally. It also offers insights into the trials.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

CBMC is an institution within the CHA Medical Group.

The collaboration is set to cover feasibility assessments, principal investigator selection, and patient recruitment facilitation.

CHA Global Clinical Trials Center director Dr Young-Sang Kim said: “Through our partnership with HiRO, we are poised to elevate our clinical research expertise and medical excellence.

“Drawing on HiRO’s presence across the US, Europe, and the Asia-Pacific region, we are reinforcing our commitment to providing more effective and pioneering treatments on a global scale, ultimately improving outcomes for patients in need.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

HiRO is set to promote the clinical research capabilities of South Korea and CBMC on a global scale, emphasising the region’s facilities, ‘skilled’ professionals, and research ‘excellence’.

The organisations are committed to exploring innovative approaches together, with the MOU marking the beginning of a joint effort to shape the future of clinical research in South Korea and internationally.

HiRO founder and CEO Dr Karen Chu said: “South Korea is a prime destination for clinical trials, with a robust healthcare infrastructure and favourable research environment.

“We are confident that this partnership will further enhance our ability to offer capital-efficient and high-quality clinical trial solutions, leading to impactful results and significant advancements in medical breakthroughs.”

HiRO offers a full spectrum of cross-border solutions and services to its clients. These services include early pre-clinical strategic planning, clinical trial design, pharmacovigilance, regulatory affairs, statistics, management of data and projects, and clinical and medical monitoring services.